The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Employment - Bayer

Phase Ib study of anti-mesothelin antibody drug conjugate anetumab ravtansine in combination with pegylated liposomal doxorubicin in platinum-resistant ovarian, fallopian tube, or primary peritoneal cancer.
 
Iurie Bulat
No Relationships to Disclose
 
Kathleen N. Moore
Consulting or Advisory Role - Advaxis; AstraZeneca (Inst); Clovis Oncology (Inst); Genentech/Roche (Inst); Immunogen (Inst); Janssen Oncology (Inst); TESARO (Inst); VBL Therapeutics (Inst)
Research Funding - Lilly (Inst); PTC Therapeutics (Inst)
Travel, Accommodations, Expenses - Genentech/Roche
 
Alexei Haceatrean
No Relationships to Disclose
 
John Woojune Chung
Employment - Bayer
 
Prabhu Rajagopalan
Employment - Bayer
 
Chenghua Xia
Employment - Bayer
 
Dirk Laurent
Employment - Bayer
 
Barrett H. Childs
No Relationships to Disclose
 
Alessandro Santin
No Relationships to Disclose